Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy
β Scribed by P. Ferenci; P. Riederer; K. Jellinger; D. F. Schafer; E. A. Jones
- Book ID
- 114796606
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 381 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Increased activation of the central benzodiazepine receptor (BZR) appears to play an important role in hepatic encephalopathy (HE). However, there is controversy regarding whether the density or affinity of BZRs is altered. A previous positron emission tomography (PET) study using the BZR antagonist
Sera of patients with hepatic encephalopathy strongly inhibit the specific binding of y-aminobutyric acid to synaptic membranes. In a previous study, this inhibition of specific y-aminobutyric acid binding was attributed to y-aminobutyric acid itself, and it was assumed that serum y-aminobutyric aci
The aim of the study was to verify the role of yaminobutyric acid in the pathogenesis of hepatic encephalopathy occurring in cirrhotic patients by attempting to correlate plasma and cerebrospinal fluid content of authentic y-aminobutyric acid with the neurological manifestations of hepatic encephalo